<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03904459</url>
  </required_header>
  <id_info>
    <org_study_id>NorJIA</org_study_id>
    <nct_id>NCT03904459</nct_id>
  </id_info>
  <brief_title>Jaw, Mouth and Bone Health, and Quality of Life in Children With Juvenile Idiopathic Arthritis (JIA)</brief_title>
  <acronym>NorJIA</acronym>
  <official_title>The Norwegian JIA Study - Temporo-mandibular Involvement, Oral Health, Uveitis, Bone Health and Quality of Life in Children With Juvenile Idiopathic Arthritis (JIA). A Large Multicentre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital of North Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oral Health Centre of Expertise Mid, North and West Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norwegian University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tromso</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Norwegian JIA Study (NorJIA) is a prospective, longitudinal, multicenter, observational
      study of 250 children with juvenile idiopathic arthritis (JIA) and 250 healthy controls,
      attending the three Norwegian university clinics in Bergen, Tromsø, or Trondheim. The study
      will run over 5 years, and include extensive clinical, laboratory, radiological and oral
      examinations at baseline and after 2 years follow-up. There will be a special focus on the
      jaw (temporomandibular joints) with extensive imaging and clinical examination, aiming at
      establishing scoring systems for active and chronic disease and growth disturbances. Another
      focus is to study mouth and teeth problems, such as caries and gingivitis, and look for
      predictors of poor oral health in children with JIA compared to health peers. As chronic
      inflammation, reduced physical activity and certain anti-inflammatory drugs can be
      detrimental for bone strength and development, the investigators also want to study the bone
      health of children with JIA, and look for predictors of poor bone mineral density. The
      results of the study may contribute to better diagnostics of inflammatory processes, earlier
      detection of poor oral or bone health, and thereby point to possible prevention strategies to
      increase quality of life for children with JIA in the future.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 25, 2015</start_date>
  <completion_date type="Anticipated">June 20, 2020</completion_date>
  <primary_completion_date type="Actual">August 17, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone mineral density</measure>
    <time_frame>2 years</time_frame>
    <description>measured by a Dual-energy X-ray absorptiometry (DXA) scan of the hip, lumbar spine and total body with body composition and expressed in Z scores, number of standard deviations (SD) from the expected mean according to sex and age</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Joint inflammation and damage</measure>
    <time_frame>2 years</time_frame>
    <description>defined according to predefined standard protocol for 3-Tesla MRI of the temporomandibular joints</description>
  </primary_outcome>
  <primary_outcome>
    <measure>caries experience DMFTS/dmfts</measure>
    <time_frame>2 years</time_frame>
    <description>Measured by: DMFTS = Number of decayed/missed/filled permanent teeth in the age group 12-17 years, or dmfts = No. of decayed/missed/filled primary teeth in children up to 11 years</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">452</enrollment>
  <condition>Arthritis, Juvenile</condition>
  <arm_group>
    <arm_group_label>cases</arm_group_label>
    <description>Children with juvenile idiopathic arthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>healthy children</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <arm_group_label>cases</arm_group_label>
    <arm_group_label>controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood, serum, stimulated and unstimulated saliva
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with juvenile idiopathic arthritis followed at any of the three participating
        centers according to hospital files. Controls are recruited at The Oral Health Centre of
        Expertise (Tk) Mid-Norway (TkMN), TkWest or at Tk Northern Norway (TkNN) from their lists
        of children due for a free visit to the dentist according to the Norwegian public dental
        service policy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  fulfilling the ILAR criteria for juvenile idiopathic arthritis

        Exclusion Criteria:

          -  no consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ansgar Berg</last_name>
    <role>Study Director</role>
    <affiliation>Department of Pediatrics, Haukeland University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oral Health Centre of Expertise West Norway</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oral Health Centre of Expertise North Norway</name>
      <address>
        <city>Tromsø</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital in North Norway</name>
      <address>
        <city>Tromsø</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oral heath Centre of Expertise Mid Norway</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://www.norjia.com</url>
    <description>Related Info</description>
  </link>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 3, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2019</study_first_posted>
  <last_update_submitted>April 3, 2019</last_update_submitted>
  <last_update_submitted_qc>April 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Temporomandibular Joint</keyword>
  <keyword>Oral Health</keyword>
  <keyword>Bone &amp; Bones</keyword>
  <keyword>Bone Density</keyword>
  <keyword>Quality of Life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

